Anti-Adenylosuccinate Lyase抗体

Cat. Number:

Anti-Adenylosuccinate Lyase抗体KL-6352R

Quantity size:

0.2ml

Concentration:

1mg/ml   Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Adenylsuccinate lyase is involved in both de novo synthesis of purines and formation of adenosine monophosphate from inosine monophosphate. It catalyzes two reactions in AMP biosynthesis: the removal of a fumarate from succinylaminoimidazole carboxamide (SAICA) ribotide to give aminoimidazole Anti-Adenylosuccinate Lyase抗体carboxamide ribotide (AICA) and removal of fumarate from adenylosuccinate to give AMP. Adenylosuccinase deficiency results in succinylpurinemic autism, psychomotor retardation, and , in some cases, growth retardation associated with muscle wasting and epilepsy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].

Also known as:

Adenylosuccinase;Anti-Adenylosuccinate Lyase抗体 Adenylosuccinate lyase; ADSL; AMPS; ASase; ASL; PUR8_HUMAN.

Specificity:

Storage:

Shipped at 4℃, Anti-Adenylosuccinate Lyase抗体Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working Anti-Adenylosuccinate Lyase抗体dilutions must be determined by the end user.